InvestingPro predicted Quantum Computing’s 48% drop 11 months early

Quantum Computing Inc. shares fell nearly 48% from $15.23 in August 2025 to a $7.92 low after an InvestingPro valuation model had estimated fair value at $8.80, 42% below the then-current share price. Despite revenue increasing to $9.824 million, EBITDA losses more than doubled to $61.116 million, reinforcing concerns over cash burn and valuation. The company has also reported earnings beats, completed a $500 million private placement, and launched a photonic computing system, but shares at $8.70 remain near the current $9.30 fair-value estimate.

Analysis

The relevant equity issue is no longer the historical valuation call but whether QUBT can convert a sharply larger capital base into contracted photonic-computing revenue before operating losses absorb the financing. The private placement reduces near-term solvency risk, but it can raise the hurdle for per-share value if warrant coverage, conversion terms, or future equity issuance are dilutive. With commercial revenue still small relative to the loss base, quarterly bookings, deferred revenue, gross margin, and cash burn—not headline product launches—will determine whether the multiple can sustain.

POET has asymmetric narrative upside from validation of its optical-interconnect platform, but a collaboration is not equivalent to a purchase commitment. The second-order risk is that QUBT's commercialization timetable slips, leaving POET with promotional association rather than meaningful module volumes; conversely, disclosed design wins or minimum-volume orders could rerate POET faster than QUBT because POET has more direct leverage to photonics component demand. The article is marketing material built around a backward-looking fair-value estimate, so it provides no independently verifiable evidence of forward unit economics or the financing's dilution profile.

Near term, QUBT remains vulnerable to financing-document disclosures and any deceleration in reported revenue growth; the principal short risk is retail/momentum re-entry following product or partnership announcements. Over 6-18 months, the decisive catalyst is evidence that revenue growth converts into improving gross profit and a declining cash-burn ratio. The bearish thesis is falsified by recurring commercial contracts sufficient to support revenue above $40-50 million annually while EBITDA losses narrow materially, rather than merely by another quarterly revenue beat from a low base.

Key Decisions for Investors

• Avoid initiating a directional QUBT long until the $500 million placement's share count, warrants, exercise prices, and use-of-proceeds are fully modeled; treat any post-financing rally without disclosed backlog as a potential short-alert rather than confirmation of commercialization.
• For a 1-3 month tactical position, consider a small QUBT short only after a momentum spike and borrow confirmation, sized modestly given meme-stock squeeze risk; cover if the company reports contracted recurring revenue, not just collaboration announcements, or if price holds above the post-financing high on rising volume.
• Monitor POET for disclosed purchase orders, qualified-product status, and customer concentration tied to QUBT. A long POET is warranted only on independently disclosed volume commitments; absent those data, the collaboration has insufficient revenue visibility to justify a standalone trade.
• Use the next two earnings reports as the key catalyst window: require sequential gross-margin improvement and cash burn below revenue growth for a constructive QUBT view. Continued EBITDA-loss expansion despite revenue growth supports maintaining a bearish bias over 6-12 months.